Gainers
- Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 28.1% to $1.46 during Tuesday's pre-market session. The company's market cap stands at $4.5 million.
- Outlook Therapeutics (NASDAQ:OTLK) shares moved upwards by 23.52% to $0.42. The market value of their outstanding shares is at $109.3 million.
- INVO Bioscience (NASDAQ:INVO) shares moved upwards by 23.3% to $1.27. The company's market cap stands at $3.1 million.
- Kronos Bio (NASDAQ:KRON) shares increased by 18.69% to $1.27. The company's market cap stands at $74.0 million.
- vTv Therapeutics (NASDAQ:VTVT) shares moved upwards by 16.2% to $11.2. The market value of their outstanding shares is at $22.8 million.
- Pluri (NASDAQ:PLUR) stock increased by 11.03% to $0.63. The company's market cap stands at $26.2 million.
Losers
- Inovio Pharmaceuticals (NASDAQ:INO) shares decreased by 20.5% to $0.55 during Tuesday's pre-market session. The company's market cap stands at $150.1 million.
- Venus Concept (NASDAQ:VERO) shares decreased by 17.56% to $1.08. The market value of their outstanding shares is at $5.9 million.
- Panbela Therapeutics (NASDAQ:PBLA) shares declined by 17.06% to $3.6. The market value of their outstanding shares is at $1.7 million.
- Aclarion (NASDAQ:ACON) stock declined by 11.88% to $2.3. The company's market cap stands at $1.9 million.
- Renalytix (NASDAQ:RNLX) shares declined by 11.84% to $0.26. The company's market cap stands at $13.2 million.
- Aravive (NASDAQ:ARAV) stock fell 11.76% to $0.04. The market value of their outstanding shares is at $3.1 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.